A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy

Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial

(2012) Andrew S. Bomback et al.   AMERICAN JOURNAL OF NEPHROLOGY

Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy

(2011) J. M. Hofstra et al.   Clinical Journal of the American Society of Nephrology

Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24

(2011) T. Rauen et al.   CLINICAL NEPHROLOGY

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy

(2011) L. H. Beck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis

(2011) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

The renaissance of corticotropin therapy in proteinuric nephropathies

(2011) Rujun Gong   Nature Reviews Nephrology

The Melanocortin System in Control of Inflammation

(2011) Anna Catania et al.   TheScientificWorldJOURNAL

Melanocortin 1 Receptor Agonists Reduce Proteinuria

(2010) A. Lindskog et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy

(2010) N. Polanco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Single Nucleotide Polymorphisms in the Phospholipase A2 Receptor Gene Are Associated with Genetic Susceptibility to Idiopathic Membranous Nephropathy

(2010) Sejoong Kim et al.   NEPHRON CLINICAL PRACTICE

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE